Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-54,991
Closed -$7.52M 486
2025
Q1
$7.52M Buy
54,991
+7,182
+15% +$1.03M 0.08% 151
2024
Q4
$7.31M Buy
+47,809
New +$8.06M 0.09% 141
2022
Q2
Sell
-4,904
Closed -$1.03M 374
2022
Q1
$1.03M Buy
4,904
+2,727
+125% +$593K 0.01% 299
2021
Q4
$522K Sell
2,177
-23,487
-92% -$6.04M ﹤0.01% 358
2021
Q3
$7.26M Buy
25,664
+71
+0.3% +$23.3K 0.04% 140
2021
Q2
$8.86M Buy
25,593
+23,821
+1,344% +$7.22M 0.05% 115
2021
Q1
$496K Buy
+1,772
New +$478K ﹤0.01% 318
2020
Q4
Sell
-3,180
Closed -$902K 372
2020
Q3
$902K Sell
3,180
-10,645
-77% -$2.97M 0.01% 238
2020
Q2
$3.7M Sell
13,825
-269,016
-95% -$80.9M 0.05% 121
2020
Q1
$89.5M Sell
282,841
-10,126
-3% -$3.07M 1.02% 14
2019
Q4
$86.9M Sell
292,967
-49,828
-15% -$13.8M 0.8% 9
2019
Q3
$79.8M Buy
342,795
+339,706
+10,997% +$79.1M 0.78% 11
2019
Q2
$722K Sell
3,089
-352,712
-99% -$81.4M 0.01% 277
2019
Q1
$84.1M Buy
355,801
+204,042
+134% +$64.3M 0.95% 7
2018
Q4
$45.7M Buy
151,759
+71,083
+88% +$22.7M 0.58% 17
2018
Q3
$28.5M Buy
80,676
+77,876
+2,781% +$26.8M 0.33% 34
2018
Q2
$813K Buy
2,800
+349
+14% +$98.1K 0.01% 240
2018
Q1
$671K Buy
+2,451
New +$761K 0.01% 259
2017
Q3
Sell
-175,000
Closed -$47.5M 184
2017
Q2
$47.5M Buy
+175,000
New +$46.3M 0.93% 12

Other funds holding BIIB

Banco Santander's BIIB Position: Q2 2025 in Review

Banco Santander sold out of Biogen (BIIB) in Q2 2025, closing a stake of 54,991 shares — an estimated $7.52M sold.

Banco Santander first reported a position in BIIB in Q2 2017 and held it in 19 quarters. The position peaked at $89.5M in Q1 2020. 866 funds tracked by Wall St. Rank hold BIIB as of Q2 2025.

  • Banco Santander reported no remaining Biogen position as of Q2 2025 after selling out during the quarter.
  • Banco Santander sold 54,991 Biogen shares in Q2 2025, an estimated $7.52M.
  • Banco Santander first reported a position in Biogen in Q2 2017 and held it in 19 quarters.
  • Banco Santander's Biogen position peaked at $89.5M in Q1 2020.
  • 866 funds tracked by Wall St. Rank held Biogen as of Q2 2025.

Based on Banco Santander's 13F filing for Q2 2025, filed 1 Aug 2025.